The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.
This post is part of a series on President Trump’s deregulatory record and what we might expect in the new administration.
Benefit-cost analysis has been part of the U.S. regulatory development process for over 40 years. The historic record, when coupled with recent actions, raises questions about its continued role ‒ in particular whether the focus will shift increasingly to considering costs without comparison to benefits.

The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.
The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.
The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.